Page values for "Insulin Aspart"
Appearance
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Insulin aspart |
| brand | String | NovoLog, Fiasp (ultra-rapid), Trurapi |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Insulins|Insulin]] • [[:Category:Rapid-acting_insulins|Rapid-acting insulin analog]] • [[:Category:Mealtime_insulins|Mealtime (bolus) insulin]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-000005EF-QINU`"', '"`UNIQ--vote-000005F0-QINU`"', '"`UNIQ--vote-000005F1-QINU`"' |
| starting_dose | String | SC 4-6 units (or 1 unit per 10-15 g carbs) at meals; titrate to postprandial glucose |
| preparations | String | 100 U/mL (NovoLog, Fiasp) vials, pens, cartridges |
| fda_max | String | Titrated to glucose; no fixed maximum |
| pill_id | Text | |
| routes | List of String, delimiter: , | Subcutaneous • IV • insulin pumps |
| onset | String | SC: 5-15 minutes (Fiasp 2.5 minutes earlier on average) |
| duration | String | 3-5 hours |
| halflife | String | ~80 minutes SC'"`UNIQ--ref-000005F2-QINU`"' |
| bioavailability | String | ~100% from subcutaneous depot |
| pregnancy | String | Insulin is the preferred glucose-lowering therapy in pregnancy; aspart is widely used.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |